Related Experiment Video
Updated: Jul 14, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
[Diabetic foot syndrome in clinical practice. II. Results after one year at the Diabetic Foot Consulting Unit]
J Sieradzki1, T Koblik, J Otfinowski
1Z Katedry i Kliniki Chorób Metabolicznych Collegium Medicum, Uniwersytetu Jagielloónskiego w Krakowie.
Abstract:
The study included 46 patients with the diabetic foot syndrome and ulcerations, and 40 patients with high-risk foot. Mean duration of hospitalization of the patients with ulcerations was 54 days, mean daily glycemia decreased from 162.5 mg% to 114.9 mg%. Ulcerations were completely healed in 93.5% of patients, whereas high and partial foot amputation was high and 3.2% of patients, respectively. The annual amputation rate was 2.3% in the entire group of diabetic foot patients (86). The present results indicate the necessity for adoption of a multidisciplinary approach to the problem of diabetic foot. It may be added that cooperation in glycemia normalization and patients education may decrease the number of amputations, and hence the degree of physical disability in diabetic foot patients.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Type I Diabetes III: Clinical Manifestations
Complications of Diabetes Mellitus
Diabetic Foot Ulcer
Diabetic Retinopathy
